Akorn adds Doxercalciferol Injection Solution in single-use vials to product line
Specialty pharmaceutical company Akorn, Inc. said Monday it has added Doxercalciferol Injection Solution in single-use vials to its product line. Doxercalciferol Injection is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Read More »
Alerts Sign-up